Startup India Government of India
Anthea Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹27.78 Cr
▲ 516% YoY
Net loss · FY 2025
₹6.1 Cr
Net margin -21.9%
EBITDA · FY 2025
₹4.86 Cr
EBITDA margin 17.5%
Authorised capital
₹650 Cr
Registered with MCA
Paid-up capital
₹310.48 Cr
Issued & subscribed
Open charges
₹800.48 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Employees · EPFO
507
Provident fund records
About Anthea Pharma Private Limited
Data last updated:
Anthea Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Yashoda Healthcare Services Private Limited and recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2019PTC136590. Its GSTIN is 36AASCA8957F1Z1 (Telangana).
The company has an authorised share capital of ₹650 Cr and a paid-up capital of ₹310.48 Cr. It is led by directors Pavan Kumar Gorukanti and Abhinav Gorukanti.
Its last annual general meeting (AGM) was held on 27 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.78 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹6.1 Cr (net margin -21.9%) and EBITDA of ₹4.86 Cr (EBITDA margin 17.5%). Revenue has grown at a compounded annual rate (CAGR) of 296% over three years.
The company has about 507 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Anthea Pharma and Graviti Pharmaceuticals. As per MCA filings, the company has open charges of ₹800.48 Cr on record. The company has 6 deals on record (3 funding rounds, 2 rights issues, 1 secondary share transfer), with disclosed funding of ₹225 Cr; the latest was in April 2022. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Aashka Formulation Private Limited with revenue of ₹27.95 Cr. The company has 8 MSME Form 1 returns on record between 2021 and 2024, listing 75 overdue payments to 13 micro and small suppliers.
For more details, the company can be reached via its website gravitipharma.com.
Company Details of Anthea Pharma Private Limited
CIN U24304TG2019PTC136590
Registration Number 136590
Incorporation Date 05 November 2019
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Yashoda Healthcare Services Private Limited
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Anthea Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressHouse No. 8 – 2 – 248/1/7/64 & 64/1 Plot No.64 Nagarjuna Co – Operative Housing Society, Punjagutta, Hyderabad, Telangana, India – 500082
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Anthea Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Anthea Pharma Private Limited
Anthea Pharma operates two associated brands: Anthea Pharma and Graviti Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides comprehensive services in formulation development, marketing, quality management, and regulatory support for pharmaceuticals. | antheapharma.com | |
| Pharmaceutical manufacturing and distribution of generics in India and globally. | gravitipharma.com |
Business Activity of Anthea Pharma Private Limited
The main business activity of Anthea Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Anthea Pharma Private Limited FY 2024 filings available
Anthea Pharma Private Limited reported revenue of ₹27.78 Cr (up 516% YoY) for FY 2025.
Revenue · FY 2025
₹27.78 Cr ▲ 516%
Net loss · FY 2025
₹6.1 Cr margin -21.9%
EBITDA · FY 2025
₹4.86 Cr margin 17.5%
Compounded Annual Growth Rate (CAGR) of Anthea Pharma Private Limited
Revenue CAGR growth
1 year
▲ 516%
3 years · compounded
▲ 296%
EBITDA CAGR growth
1 year
▲ 199%
3 years · compounded
▲ 49%
5 years · compounded
▲ 68%
Revenue has grown at a compounded annual rate (CAGR) of 296% over three years, including 516% growth in the latest year. EBITDA rose 199% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Anthea Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.86 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹6.1 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Anthea Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -21.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Anthea Pharma are in the company report.
Premium access
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Anthea Pharma Private Limited
Anthea Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pavan Kumar Gorukanti | Director | 31 Aug 2020 | 6 Years 1 Months | Current |
| Abhinav Gorukanti Also directs: Aurus Innovation Centre, Manerick Medicare Services Private Limited, Avalok Consultancy LLP and 4 more | Director | 05 Nov 2019 | 6 Years 11 Months | Current |
Peer Comparison of Anthea Pharma Private Limited
Anthea Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aashka Formulation Private Limited | ₹27.95 Cr (FY 2022) | •••• | •••• | 904.0% | •••• | Kalol, Gujarat, India |
| Danashmand Organic Private Limited | ₹27.92 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Mumbai, Maharashtra, India |
| Shreepati Pharmaceuticals Pvt Ltd | ₹27.91 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Indore, M.P, Madhya Pradesh, India |
| Sellwell Pharmaceuticals Limited | ₹27.85 Cr (FY 2024) | •••• | •••• | -21.0% | •••• | Madhya Pradesh, India |
| Memphis Vision Care Private Limited | ₹27.83 Cr (FY 2024) | •••• | •••• | 106.0% | •••• | Chhatral, Gujarat, India |
| Anthea Pharma Private Limited this company | ₹27.78 Cr (FY 2025) | •••• | •••• | 516.0% | •••• | Hyderabad, Telangana, India |
| Elvia Care Private Limited | ₹27.66 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Yamumanagar, Haryana, India |
| Sain Medicaments Private Limited | ₹27.64 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Telangana, India |
| Jips Pharmaceuticals Private Limited | ₹27.63 Cr (FY 2023) | •••• | •••• | 19.0% | •••• | Chandigarh, India |
| Unifaith Biotech Private Limited | ₹27.62 Cr (FY 2024) | •••• | •••• | 32.0% | •••• | New Delhi, Delhi, India |
| Quixotic Pharma Private Limited | ₹27.58 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Punjab, India |
Peers are the five companies nearest above and the five nearest below Anthea Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Anthea Pharma Private Limited
Anthea Pharma Private Limited is audited by Visweswara Rao & Associates for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Visweswara Rao & Associates | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Anthea Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Anthea Pharma Private Limited
Open charges
₹800.48 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Oct 2024 | Others | ₹50 Cr | Open |
| 23 Oct 2024 | Others | ₹200 Cr | Open |
| 22 Feb 2023 | Others | ₹47.61 Lakh | Open |
| 31 May 2022 | Canara Bank | ₹550 Cr | Open |
Total charge records: 4 View all charges
Deals & Funding of Anthea Pharma Private Limited
Anthea Pharma Private Limited has 6 deals on record (3 funding rounds, 2 rights issues, 1 secondary share transfer), with disclosed funding of ₹225 Cr; the latest was in April 2022.
Total deals
6
Funding rounds
3
Rights issues
2
Secondary share transfer
1
Disclosed funding
₹225 Cr
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2022 | Funding round | ₹75 Cr | Investors: Yashoda Healthcare Services Limited |
| Oct 2021 | Funding round | ₹125 Cr | Investors: Yashoda Healthcare Services Limited |
| Aug 2021 | Funding round | ₹25 Cr | Investors: Yashoda Healthcare Services Limited |
| May 2021 | Rights issue | ₹4 Cr | Investors: 2 individuals |
| Jan 2021 | Rights issue | ₹30 Cr | Investors: Yashoda Healthcare Services Limited |
Premium access
Full deal history
All 6 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
MSME Payment Delays by Anthea Pharma Private Limited
Anthea Pharma Private Limited has 8 MSME Form 1 returns on record between 2021 and 2024, listing 75 overdue payments to 13 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 13)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Lakshmi Venkateshwara Enterprises | •••• | •••• | •••• |
| Venkatasai Lifesciences | •••• | •••• | •••• |
| Lab Needs Private Limited | •••• | •••• | •••• |
| Lab Needs | •••• | •••• | •••• |
| Simson Pharma Limited | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 8 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Anthea Pharma Private Limited
Anthea Pharma Private Limited has a workforce of 507 employees as of Apr 01, 2025.
Employee count
507
Active EPFO establishments
1
Employee growth
50%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Anthea Pharma Private Limited
Anthea Pharma Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Ravender Gorukanti Rao ceased to be Director on 06 Sep 2021.
Charges
A charge with Others of Rs. 50.00 Cr registered on 23 Oct 2024 with Charge ID 101011788 was modified on 31 Oct 2025.
Charges
A charge with Others amounted to Rs. 200.00 Cr with Charge ID 101011789 was registered on 23 Oct 2024.
Charges
A charge with Others amounted to Rs. 50.00 Cr with Charge ID 101011788 was registered on 23 Oct 2024.
AGM
Anthea Pharma Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records.
Filing
Anthea Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 0.48 Cr with Charge ID 100701119 was registered on 22 Feb 2023.
Charges
A charge with Canara Bank amounted to Rs. 550.00 Cr with Charge ID 100595137 was registered on 31 May 2022.
Ceased
Ravender Gorukanti Rao ceased to be Director.
Ceased
Pavan Kumar Gorukanti ceased to be Additional Director.
Appointed
Pavan Kumar Gorukanti was appointed as Director.
Appointed
Abhinav Gorukanti was appointed as Director.
Incorporation
05 Nov 2019
Anthea Pharma Private Limited was registered on 05 Nov 2019 with Roc Hyderabad & aged 6 years 11 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Anthea Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Anthea Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Anthea Pharma Private Limited
Anthea Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AASCA8957F1Z1 | Telangana | Active | 17 Dec 2019 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Anthea Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anthea Pharma Private Limited
Anthea Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 November 2019 (7+ years old) and is registered under CIN U24304TG2019PTC136590.
Anthea Pharma reported revenue of ₹27.78 Cr for FY 2025 (up 516% YoY).
Anthea Pharma has 2 current directors:
- Pavan Kumar Gorukanti - Director
- Abhinav Gorukanti - Director
Anthea Pharma reported a net loss of ₹6.1 Cr (net margin -21.9%) and EBITDA of ₹4.86 Cr (EBITDA margin 17.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Anthea Pharma is 296% over three years. In the latest year (FY 2025) revenue rose 516%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Anthea Pharma is 36AASCA8957F1Z1, registered in Telangana.
The CIN (Corporate Identification Number) of Anthea Pharma is U24304TG2019PTC136590. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anthea Pharma was incorporated on 05 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
Anthea Pharma has 6 deals on record (3 funding rounds, 2 rights issues, 1 secondary share transfer), with disclosed funding of ₹225 Cr; the latest was in April 2022.
The peers of Anthea Pharma by revenue are Aashka Formulation Private Limited, Danashmand Organic Private Limited, Shreepati Pharmaceuticals Pvt Ltd, Sellwell Pharmaceuticals Limited, Memphis Vision Care Private Limited and 5 more, all in the Pharma industry (Formulations).
Ravender Gorukanti Rao ceased to be Director on 06 Sep 2021. Pavan Kumar Gorukanti ceased to be Additional Director on 30 Nov 2020. Pavan Kumar Gorukanti was appointed as Director on 31 Aug 2020. Anthea Pharma has 4 board changes on record in total.
Yes, Anthea Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).